StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMAug 3, 2026, 04:13 PM

Oramed Pharmaceuticals Schedules 2026 Annual Meeting

AI Summary

Oramed Pharmaceuticals Inc. has scheduled its 2026 Annual Meeting of Stockholders for September 15, 2026. Key proposals include the election of six directors, ratification of the independent auditor, and approval of an amendment to the Long-Term Incentive Plan to increase authorized shares by 3,000,000 to a total of 12,500,000. Stockholders will also cast advisory votes on executive compensation and the frequency of future Say on Pay votes, with the Board recommending every three years for the latter. The record date for voting is July 20, 2026.

Key Highlights

  • Annual Meeting of Stockholders scheduled for September 15, 2026.
  • Proposals include election of six directors to the Board.
  • Ratification of Kesselman & Kesselman as independent auditors for 2026.
  • Approval to increase shares for Long-Term Incentive Plan by 3,000,000 to 12,500,000.
  • Advisory vote on named executive officers' compensation (Say on Pay).
  • Advisory vote on frequency of future Say on Pay votes (Board recommends every three years).
  • Record date for voting is July 20, 2026.